In March 2025, the company announced new plans for the immediate-to-buyer featuring of its Wegovy weight loss drug. The company founded a brand new pharmacy, named NovoCare, which might cost customers $499 each month for access to the drug, under fifty percent the price of the drug by other pharmaceutical distribution networks.[53]Scientific tests